Wanda Castro-Borrero

511 total citations
12 papers, 368 citations indexed

About

Wanda Castro-Borrero is a scholar working on Pathology and Forensic Medicine, Immunology and Dermatology. According to data from OpenAlex, Wanda Castro-Borrero has authored 12 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 4 papers in Immunology and 2 papers in Dermatology. Recurrent topics in Wanda Castro-Borrero's work include Multiple Sclerosis Research Studies (11 papers), Immunotherapy and Immune Responses (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Wanda Castro-Borrero is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Immunotherapy and Immune Responses (3 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). Wanda Castro-Borrero collaborates with scholars based in United States, Germany and United Kingdom. Wanda Castro-Borrero's co-authors include Elliot M. Frohman, Teresa C. Frohman, Gary E. Lemack, Katherine Treadaway, Angela Flores, Diana Logan, Benjamin Greenberg, Donna Graves, Sophie G. Fletcher and Gina Remington and has published in prestigious journals such as Neurology, Experimental Neurology and Journal of Neurology.

In The Last Decade

Wanda Castro-Borrero

12 papers receiving 356 citations

Peers

Wanda Castro-Borrero
Refujia Gomez United States
Amer Awad United States
R. Gold Germany
A Calò Italy
C. T. Bever United States
Refujia Gomez United States
Wanda Castro-Borrero
Citations per year, relative to Wanda Castro-Borrero Wanda Castro-Borrero (= 1×) peers Refujia Gomez

Countries citing papers authored by Wanda Castro-Borrero

Since Specialization
Citations

This map shows the geographic impact of Wanda Castro-Borrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanda Castro-Borrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanda Castro-Borrero more than expected).

Fields of papers citing papers by Wanda Castro-Borrero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanda Castro-Borrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanda Castro-Borrero. The network helps show where Wanda Castro-Borrero may publish in the future.

Co-authorship network of co-authors of Wanda Castro-Borrero

This figure shows the co-authorship network connecting the top 25 collaborators of Wanda Castro-Borrero. A scholar is included among the top collaborators of Wanda Castro-Borrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanda Castro-Borrero. Wanda Castro-Borrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Salvetti, Marco, et al.. (2024). Safety and clinical effectiveness of peginterferon beta-1a for relapsing multiple sclerosis in a real-world setting: Final results from the Plegridy Observational Program. Multiple Sclerosis Journal - Experimental Translational and Clinical. 10(2). 3110601832–3110601832. 4 indexed citations
2.
Kappos, Ludwig, Stanley Cohan, Douglas L. Arnold, et al.. (2021). Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination. Therapeutic Advances in Neurological Disorders. 14. 1279209509–1279209509. 4 indexed citations
3.
Rivera, Víctor M., et al.. (2021). Sociodemographic and Clinical Characteristics of Patients With Multiple Sclerosis by Race and Ethnicity (NARCRMS Registry) (1703). Neurology. 96(15_supplement). 1 indexed citations
4.
Fitzgerald, Kathryn C., Lana Zhovtis Ryerson, Leigh Charvet, et al.. (2021). Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis. Neurology. 97(9). e881–e889. 40 indexed citations
5.
Gold, Ralf, Ernst‐Wilhelm Radue, Gavin Giovannoni, et al.. (2020). Long-term safety and efficacy of daclizumab beta in relapsing–remitting multiple sclerosis: 6-year results from the SELECTED open-label extension study. Journal of Neurology. 267(10). 2851–2864. 8 indexed citations
6.
Giovannoni, Gavin, Heinz Wiendl, Benjamin Turner, et al.. (2017). Circulating lymphocyte levels and relationship with infection status in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta. Multiple Sclerosis Journal. 24(13). 1725–1736. 3 indexed citations
7.
Benedict, Ralph H. B., Stanley Cohan, Sharon Lynch, et al.. (2017). Improved cognitive outcomes in patients with relapsing–remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study. Multiple Sclerosis Journal. 24(6). 795–804. 35 indexed citations
9.
Nicaise, Alexandra M., Rosa M. Guzzo, Wanda Castro-Borrero, et al.. (2016). iPS-derived neural progenitor cells from PPMS patients reveal defect in myelin injury response. Experimental Neurology. 288. 114–121. 51 indexed citations
10.
Castro-Borrero, Wanda, Donna Graves, Teresa C. Frohman, et al.. (2012). Current and emerging therapies in multiple sclerosis: a systematic review. Therapeutic Advances in Neurological Disorders. 5(4). 205–220. 105 indexed citations
11.
Courtney, Ardith, Wanda Castro-Borrero, Scott L. Davis, Teresa C. Frohman, & Elliot M. Frohman. (2011). Functional treatments in multiple sclerosis. Current Opinion in Neurology. 24(3). 250–254. 22 indexed citations
12.
Fletcher, Sophie G., Wanda Castro-Borrero, Gina Remington, et al.. (2009). Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nature Clinical Practice Urology. 6(2). 96–107. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026